Literature DB >> 20703094

Does Huntingtin play a role in selective macroautophagy?

Joan S Steffan1.   

Abstract

The accumulation of protein aggregates in neurons appears to be a basic feature of neurodegenerative disease. In Huntington's Disease (HD), a progressive and ultimately fatal neurodegenerative disorder caused by an expansion of the polyglutamine repeat within the protein Huntingtin (Htt), the immediate proximal cause of disease is well understood. However, the cellular mechanisms which modulate the rate at which fragments of Htt containing polyglutamine accumulate in neurons is a central issue in the development of approaches to modulate the rate and extent of neuronal loss in this disease. We have recently found that Htt is phosphorylated by the kinase IKK on serine (S) 13, activating its phosphorylation on S16 and its acetylation and poly-SUMOylation, modifications that modulate its clearance by the proteasome and lysosome in cells. In the discussion here I suggest that Htt may have a normal function in the lysosomal mechanism of selective macroautophagy involved in its own degradation which may share some similarity with the yeast cytoplasm to vacuole targeting (Cvt) pathway. Pharmacologic activation of this pathway may be useful early in disease progression to treat HD and other neurodegenerative diseases characterized by the accumulation of disease proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703094      PMCID: PMC3047613          DOI: 10.4161/cc.9.17.12718

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  162 in total

1.  Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.

Authors:  Anthone W Dunah; Hyunkyung Jeong; April Griffin; Yong-Man Kim; David G Standaert; Steven M Hersch; M Maral Mouradian; Anne B Young; Naoko Tanese; Dimitri Krainc
Journal:  Science       Date:  2002-05-02       Impact factor: 47.728

2.  Cooperative binding of the cytoplasm to vacuole targeting pathway proteins, Cvt13 and Cvt20, to phosphatidylinositol 3-phosphate at the pre-autophagosomal structure is required for selective autophagy.

Authors:  Daniel C Nice; Trey K Sato; Per E Stromhaug; Scott D Emr; Daniel J Klionsky
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

3.  LAMP-2: a control step for phagosome and autophagosome maturation.

Authors:  Paul Saftig; Wouter Beertsen; Eeva-Liisa Eskelinen
Journal:  Autophagy       Date:  2008-02-13       Impact factor: 16.016

4.  Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.

Authors:  Effat S Emamian; Michael D Kaytor; Lisa A Duvick; Tao Zu; Susan K Tousey; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  Neuron       Date:  2003-05-08       Impact factor: 17.173

5.  Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Hung-Kai Chen; Pedro Fernandez-Funez; Summer F Acevedo; Yung C Lam; Michael D Kaytor; Michael H Fernandez; Alastair Aitken; Efthimios M C Skoulakis; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

6.  Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.

Authors:  Valérie Lallemand-Breitenbach; Marion Jeanne; Shirine Benhenda; Rihab Nasr; Ming Lei; Laurent Peres; Jun Zhou; Jun Zhu; Brian Raught; Hugues de Thé
Journal:  Nat Cell Biol       Date:  2008-04-13       Impact factor: 28.824

7.  Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila.

Authors:  H Y Edwin Chan; John M Warrick; Isabella Andriola; Diane Merry; Nancy M Bonini
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

8.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

Authors:  Sandrine Humbert; Elzbieta A Bryson; Fabrice P Cordelières; Nathan C Connors; Sandeep R Datta; Steven Finkbeiner; Michael E Greenberg; Frédéric Saudou
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

9.  Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.

Authors:  Andrea Williams; Sovan Sarkar; Paul Cuddon; Evangelia K Ttofi; Shinji Saiki; Farah H Siddiqi; Luca Jahreiss; Angeleen Fleming; Dean Pask; Paul Goldsmith; Cahir J O'Kane; Rodrigo Andres Floto; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

10.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.

Authors:  Emma Hockly; Victoria M Richon; Benjamin Woodman; Donna L Smith; Xianbo Zhou; Eddie Rosa; Kirupa Sathasivam; Shabnam Ghazi-Noori; Amarbirpal Mahal; Philip A S Lowden; Joan S Steffan; J Lawrence Marsh; Leslie M Thompson; Cathryn M Lewis; Paul A Marks; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

View more
  39 in total

1.  Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin.

Authors:  Dale D O Martin; Ryan J Heit; Megan C Yap; Michael W Davidson; Michael R Hayden; Luc G Berthiaume
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

2.  Huntingtin facilitates selective autophagy.

Authors:  Amir Gelman; Moran Rawet-Slobodkin; Zvulun Elazar
Journal:  Nat Cell Biol       Date:  2015-03       Impact factor: 28.824

Review 3.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Drug Discov Today       Date:  2014-03-13       Impact factor: 7.851

5.  Rhes suppression enhances disease phenotypes in Huntington's disease mice.

Authors:  John H Lee; Matthew J Sowada; Ryan L Boudreau; Andrea M Aerts; Daniel R Thedens; Peg Nopoulos; Beverly L Davidson
Journal:  J Huntingtons Dis       Date:  2014

6.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

Review 7.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

8.  Structure and function of yeast Atg20, a sorting nexin that facilitates autophagy induction.

Authors:  Hana Popelka; Alejandro Damasio; Jenny E Hinshaw; Daniel J Klionsky; Michael J Ragusa
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-07       Impact factor: 11.205

9.  Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.

Authors:  Robert G Mealer; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

10.  Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.

Authors:  Haiqun Jia; Ryan J Kast; Joan S Steffan; Elizabeth A Thomas
Journal:  Hum Mol Genet       Date:  2012-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.